{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:57:32Z","timestamp":1781639852232,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["France 2030\u2013Plan de relance\u2013mesure de pr\u00e9servation de l\u2019emploi R&D"],"award-info":[{"award-number":["France 2030\u2013Plan de relance\u2013mesure de pr\u00e9servation de l\u2019emploi R&D"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["France 2030\u2013Plan de relance\u2013mesure de pr\u00e9servation de l\u2019emploi R&D"],"award-info":[{"award-number":["France 2030\u2013Plan de relance\u2013mesure de pr\u00e9servation de l\u2019emploi R&D"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["France 2030\u2013Plan de relance\u2013mesure de pr\u00e9servation de l\u2019emploi R&D"],"award-info":[{"award-number":["France 2030\u2013Plan de relance\u2013mesure de pr\u00e9servation de l\u2019emploi R&D"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["France 2030\u2013Plan de relance\u2013mesure de pr\u00e9servation de l\u2019emploi R&D"],"award-info":[{"award-number":["France 2030\u2013Plan de relance\u2013mesure de pr\u00e9servation de l\u2019emploi R&D"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Valbiotis"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lifestyle interventions constitute first-line strategies for the management of metabolic dysfunction-associated steatotic liver disease (MASLD), with dietary modification and increased physical activity forming the core evidence-based approaches. In this framework, plant-based supplements are being investigated as potential adjunctive strategies. Totum-448, a polyphenol-rich plant formulation, has shown promising effects in preclinical studies. Here, we evaluated the effects of Totum-448, voluntary exercise (Vex), and their combination in a hamster model of MASLD. Fifty-four male golden Syrian hamsters were fed either a normal diet (ND) or a Western diet (WD) for six weeks. WD-fed animals were then randomized to receive WD alone, WD supplemented with Totum-448 (5% w\/w), WD with Vex, or WD with both interventions for an additional five weeks. We hypothesized that only the combined intervention would elicit measurable benefits. Contrary to this hypothesis, distinct effects were observed for each intervention: Totum-448 reduced circulating lipid levels and downregulated hepatic markers of inflammation and fibrosis, whereas Vex improved body composition, increased energy expenditure, and reduced hepatic lipid content. No significant improvements were detected in histological markers of inflammation or fibrosis. The combined intervention did not provide additional benefits beyond those of the individual interventions. In conclusion, Totum-448 and Vex exert complementary effects in MASLD. Although no additive effects were observed, the combined intervention provided the broadest overall protection by preserving the benefits of each intervention alone. These findings support the relevance of combining exercise with plant-based nutritional strategies in the management of MASLD.<\/jats:p>","DOI":"10.1038\/s41598-026-43177-5","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:24:32Z","timestamp":1773077072000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential effects of voluntary exercise and Totum-448, a plant-based formulation, in a hamster model of MASLD"],"prefix":"10.1038","volume":"16","author":[{"given":"Vivien","family":"Chavanelle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00ebl","family":"Ennequin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doriane","family":"Ripoche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda F.","family":"Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian Le","family":"Joubioux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Maugard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Hervieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Peltier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Sirvent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"43177_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatol. Baltim. Md. https:\/\/doi.org\/10.1097\/HEP.0000000000000520 (2023).","journal-title":"Hepatol. Baltim. Md."},{"key":"43177_CR2","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1136\/gutjnl-2023-330110","volume":"72","author":"E En Li Cho","year":"2023","unstructured":"En Li Cho, E. et al. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis. Gut 72, 2138\u20132148 (2023).","journal-title":"Gut"},{"key":"43177_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek, J. et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 8, 20\u201330 (2023).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"43177_CR4","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatol. Baltim. Md. 77, 1335\u20131347 (2023).","journal-title":"Hepatol. Baltim. Md."},{"key":"43177_CR5","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi, K. et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 7, 851\u2013861 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"43177_CR6","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.jhep.2022.07.004","volume":"77","author":"AM Allen","year":"2022","unstructured":"Allen, A. M. et al. Clinical course of non-alcoholic fatty liver disease and the implications for clinical trial design. J. Hepatol. 77, 1237\u20131245 (2022).","journal-title":"J. Hepatol."},{"key":"43177_CR7","unstructured":"FDA. FDA Approves First Treatment for Patients with Liver Scarring Due to Fatty Liver Disease. FDA (2024). https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-patients-liver-scarring-due-fatty-liver-disease."},{"key":"43177_CR8","doi-asserted-by":"publisher","first-page":"e70904","DOI":"10.1002\/fsn3.70904","volume":"13","author":"V Chavanelle","year":"2025","unstructured":"Chavanelle, V. et al. Totum-448 Improves MASLD and Modulates Microbiota in Hamsters: Dose\u2013Response Study and Effects of Supplementation Cessation. Food Sci. Nutr. 13, e70904 (2025).","journal-title":"Food Sci. Nutr."},{"key":"43177_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s44355-025-00033-z","volume":"2","author":"JM Lambooij","year":"2025","unstructured":"Lambooij, J. M. et al. The polyphenol-rich plant extract Totum-448 decreases hepatic steatosis and inflammation in diet-induced MASLD mice. Npj Gut Liver. 2, 20 (2025).","journal-title":"Npj Gut Liver"},{"key":"43177_CR10","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","author":"European Association for the Study of the Liver (EASL)","year":"2016","unstructured":"European Association for the Study of the Liver (EASL). European Association for the Study of Diabetes (EASD), & European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol. 64, 1388\u20131402 (2016).","journal-title":"J. Hepatol."},{"key":"43177_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani, N. et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67, 328 (2018).","journal-title":"Hepatology"},{"key":"43177_CR12","doi-asserted-by":"publisher","first-page":"i4428","DOI":"10.1136\/bmj.i4428","volume":"354","author":"J Glen","year":"2016","unstructured":"Glen, J., Floros, L., Day, C. & Pryke, R. Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance. BMJ 354, i4428 (2016).","journal-title":"BMJ"},{"key":"43177_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2337\/ds17-0013","volume":"30","author":"CE Cox","year":"2017","unstructured":"Cox, C. E. Role of Physical Activity for Weight Loss and Weight Maintenance. Diabetes Spectr. Publ Am. Diabetes Assoc. 30, 157\u2013160 (2017).","journal-title":"Diabetes Spectr. Publ Am. Diabetes Assoc."},{"key":"43177_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40279-018-01041-1","volume":"49","author":"C Pickering","year":"2019","unstructured":"Pickering, C. & Kiely, J. Do Non-Responders to Exercise Exist\u2014and If So, What Should We Do About Them? Sports Med. Auckl. Nz. 49, 1\u20137 (2019).","journal-title":"Sports Med. Auckl. Nz"},{"key":"43177_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.14740\/jocmr5113","volume":"16","author":"K Deshpande","year":"2024","unstructured":"Deshpande, K., Olynyk, J., Ayonrinde, O. & Nosaka, K. Barriers to Exercise in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Patient Survey. J. Clin. Med. Res. 16, 94\u2013105 (2024).","journal-title":"J. Clin. Med. Res."},{"key":"43177_CR16","doi-asserted-by":"publisher","first-page":"G874","DOI":"10.1152\/ajpgi.00510.2010","volume":"300","author":"RS Rector","year":"2011","unstructured":"Rector, R. S. et al. Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model. Am. J. Physiol. -Gastrointest Liver Physiol. 300, G874\u2013G883 (2011).","journal-title":"Am. J. Physiol. -Gastrointest Liver Physiol."},{"key":"43177_CR17","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1017\/S0007114522002562","volume":"129","author":"F Abdulqader","year":"2023","unstructured":"Abdulqader, F., Yu, L., Vickers, M. H., Firth, E. C. & McGlashan, S. R. Voluntary physical activity in early life attenuates markers of fatty liver disease in adult male rats fed a high-fat diet. Br. J. Nutr. 129, 1667\u20131676 (2023).","journal-title":"Br. J. Nutr."},{"key":"43177_CR18","doi-asserted-by":"publisher","first-page":"e15993","DOI":"10.14814\/phy2.15993","volume":"12","author":"C Besqueut-Rougerie","year":"2024","unstructured":"Besqueut-Rougerie, C. et al. Voluntary exercise fails to prevent metabolic dysfunction-associated steatotic liver disease progression in male rats fed a high-fat high-cholesterol diet. Physiol. Rep. 12, e15993 (2024).","journal-title":"Physiol. Rep."},{"key":"43177_CR19","doi-asserted-by":"publisher","first-page":"1454980","DOI":"10.3389\/fmed.2024.1454980","volume":"11","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Signaling pathways that activate hepatic stellate cells during liver fibrosis. Front. Med. 11, 1454980 (2024).","journal-title":"Front. Med."},{"key":"43177_CR20","first-page":"394","volume":"43","author":"C Santangelo","year":"2007","unstructured":"Santangelo, C. et al. Polyphenols, intracellular signalling and inflammation. Ann. Ist Super Sanita. 43, 394\u2013405 (2007).","journal-title":"Ann. Ist Super Sanita"},{"key":"43177_CR21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/ijms24010380","volume":"24","author":"F Pojero","year":"2022","unstructured":"Pojero, F. et al. Effects of Oleuropein and Hydroxytyrosol on Inflammatory Mediators: Consequences on Inflammaging. Int. J. Mol. Sci. 24, 380 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"43177_CR22","doi-asserted-by":"publisher","first-page":"943911","DOI":"10.3389\/fnut.2022.943911","volume":"9","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. The Biological Activity Mechanism of Chlorogenic Acid and Its Applications in Food Industry: A Review. Front. Nutr. 9, 943911 (2022).","journal-title":"Front. Nutr."},{"key":"43177_CR23","doi-asserted-by":"publisher","unstructured":"Dias, K. A. et al. Anti-inflammatory and antioxidant effects of anthocyanins in Nonalcoholic fatty liver disease (NAFLD): A systematic review of in vivo studies. Crit. Rev. Food Sci. Nutr. 1\u201318. https:\/\/doi.org\/10.1080\/10408398.2025.2472882 (2025).","DOI":"10.1080\/10408398.2025.2472882"},{"key":"43177_CR24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.4162\/nrp.2019.13.6.473","volume":"13","author":"CM Park","year":"2019","unstructured":"Park, C. M. & Song, Y. S. Luteolin and luteolin-7-O-glucoside protect against acute liver injury through regulation of inflammatory mediators and antioxidative enzymes in GalN\/LPS-induced hepatitic ICR mice. Nutr. Res. Pract. 13, 473\u2013479 (2019).","journal-title":"Nutr. Res. Pract."},{"key":"43177_CR25","doi-asserted-by":"crossref","unstructured":"Hussain, T. et al. Oxidative Stress and Inflammation: What Polyphenols Can Do for Us? Oxid. Med. Cell. Longev. 7432797 (2016).","DOI":"10.1155\/2016\/7432797"},{"key":"43177_CR26","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.mam.2005.07.006","volume":"26","author":"F Johnson","year":"2005","unstructured":"Johnson, F. & Giulivi, C. Superoxide dismutases and their impact upon human health. Mol. Aspects Med. 26, 340\u2013352 (2005).","journal-title":"Mol. Aspects Med."},{"key":"43177_CR27","doi-asserted-by":"publisher","first-page":"109461","DOI":"10.1016\/j.foodres.2020.109461","volume":"137","author":"HA Gonz\u00e1lez-Ponce","year":"2020","unstructured":"Gonz\u00e1lez-Ponce, H. A. et al. Betacyanins, major components in Opuntia red-purple fruits, protect against acetaminophen-induced acute liver failure. Food Res. Int. 137, 109461 (2020).","journal-title":"Food Res. Int."},{"key":"43177_CR28","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3390\/nu2121231","volume":"2","author":"R Tsao","year":"2010","unstructured":"Tsao, R. Chemistry and Biochemistry of Dietary Polyphenols. Nutrients 2, 1231\u20131246 (2010).","journal-title":"Nutrients"},{"key":"43177_CR29","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/0031-9384(80)90402-3","volume":"24","author":"KT Borer","year":"1980","unstructured":"Borer, K. T. Characteristics of growth-inducing exercise. Physiol. Behav. 24, 713\u2013720 (1980).","journal-title":"Physiol. Behav."},{"key":"43177_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0047-6374(86)90114-4","volume":"37","author":"ME Zacour","year":"1986","unstructured":"Zacour, M. E. & Gardiner, P. F. Long-term mild endurance exercise effects on the age-associated evolution of hindlimb muscle characteristics in hamsters. Mech. Ageing Dev. 37, 13\u201326 (1986).","journal-title":"Mech. Ageing Dev."},{"key":"43177_CR31","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1161\/01.CIR.89.2.836","volume":"89","author":"T Tomita","year":"1994","unstructured":"Tomita, T. et al. Chronic dynamic exercise improves a functional abnormality of the G stimulatory protein in cardiomyopathic BIO 53.58 Syrian hamsters. Circulation 89, 836\u2013845 (1994).","journal-title":"Circulation"},{"key":"43177_CR32","first-page":"2054","volume":"1985 88","author":"LM Heunks","year":"2000","unstructured":"Heunks, L. M., Bast, A., van Herwaarden, C. L., Haenen, G. R. & Dekhuijzen, P. N. Effects of emphysema and training on glutathione oxidation in the hamster diaphragm. J. Appl. Physiol. Bethesda Md. 1985 88, 2054\u20132061 (2000).","journal-title":"J. Appl. Physiol. Bethesda Md."},{"key":"43177_CR33","doi-asserted-by":"publisher","first-page":"102114","DOI":"10.1016\/j.gde.2023.102114","volume":"83","author":"CH Cho","year":"2023","unstructured":"Cho, C. H., Patel, S. & Rajbhandari, P. Adipose tissue lipid metabolism: lipolysis. Curr. Opin. Genet. Dev. 83, 102114 (2023).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"43177_CR34","doi-asserted-by":"publisher","first-page":"R199","DOI":"10.1530\/JME-13-0277","volume":"52","author":"TS Nielsen","year":"2014","unstructured":"Nielsen, T. S., Jessen, N., J\u00f8rgensen, J. O. L., M\u00f8ller, N. & Lund, S. Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease. J. Mol. Endocrinol. 52, R199\u2013R222 (2014).","journal-title":"J. Mol. Endocrinol."},{"key":"43177_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-32556-z","author":"F Wauquier","year":"2025","unstructured":"Wauquier, F. et al. Bioavailable human metabolites from TOTUM-448 (plant-based formulation) maintain liver cell functionality in a hyperlipidic context that drives MASLD onset. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-025-32556-z (2025).","journal-title":"Sci. Rep."},{"key":"43177_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair, A. B. & Jacob, S. A simple practice guide for dose conversion between animals and human. J. Basic. Clin. Pharm. 7, 27\u201331 (2016).","journal-title":"J. Basic. Clin. Pharm."},{"key":"43177_CR37","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jff.2014.09.001","volume":"18","author":"I Hassen","year":"2015","unstructured":"Hassen, I., Casabianca, H. & Hosni, K. Biological activities of the natural antioxidant oleuropein: Exceeding the expectation \u2013 A mini-review. J. Funct. Foods. 18, 926\u2013940 (2015).","journal-title":"J. Funct. Foods"},{"key":"43177_CR38","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3390\/nu16070924","volume":"16","author":"V Nguyen","year":"2024","unstructured":"Nguyen, V., Taine, E. G., Meng, D., Cui, T. & Tan, W. Chlorogenic Acid: A Systematic Review on the Biological Functions, Mechanistic Actions, and Therapeutic Potentials. Nutrients 16, 924 (2024).","journal-title":"Nutrients"},{"key":"43177_CR39","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.3390\/nu15245056","volume":"15","author":"C Langhi","year":"2023","unstructured":"Langhi, C. et al. Totum-070, a Polyphenol-Rich Plant Extract, Prevents Hypercholesterolemia in High-Fat Diet-Fed Hamsters by Inhibiting Intestinal Cholesterol Absorption. Nutrients 15, 5056 (2023).","journal-title":"Nutrients"},{"key":"43177_CR40","unstructured":"Russell, W. M. S. & Burch, R. L. The Principles of Humane Experimental TechniqueMethuen,. (1959)."},{"key":"43177_CR41","doi-asserted-by":"publisher","first-page":"e0237096","DOI":"10.1371\/journal.pone.0237096","volume":"15","author":"R Eenige","year":"2020","unstructured":"Eenige, R. et al. RandoMice, a novel, user-friendly randomization tool in animal research. PLOS ONE. 15, e0237096 (2020).","journal-title":"PLOS ONE"},{"key":"43177_CR42","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/cdn\/nzac077.039","volume":"6","author":"K Stevenson","year":"2022","unstructured":"Stevenson, K. & Ward, R. Effect of Optimizing Fiber Intake of Mice on Weight Gain, Fat Mass, Oral Glucose and Insulin Tolerance Tests in Mice Fed a High Fat Diet. Curr. Dev. Nutr. 6, 536 (2022).","journal-title":"Curr. Dev. Nutr."},{"key":"43177_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1113\/jphysiol.1949.sp004363","volume":"109","author":"JB Weir","year":"1949","unstructured":"Weir, J. B. de V. New methods for calculating metabolic rate with special reference to protein metabolism. J. Physiol. 109, 1\u20139 (1949).","journal-title":"J. Physiol."},{"key":"43177_CR44","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1038\/s42255-025-01360-4","volume":"7","author":"AS Banks","year":"2025","unstructured":"Banks, A. S. et al. A consensus guide to preclinical indirect calorimetry experiments. Nat. Metab. 7, 1765\u20131780 (2025).","journal-title":"Nat. Metab."},{"key":"43177_CR45","first-page":"e209190","volume":"78","author":"PM Lavrut","year":"2023","unstructured":"Lavrut, P. M. et al. Histological features of liver disease development in the Atp7b\u2013\/\u2013 mouse: a model of Wilson\u2019s disease. J. Clin. Pathol. 78, e209190 (2023).","journal-title":"J. Clin. Pathol."},{"key":"43177_CR46","doi-asserted-by":"crossref","unstructured":"Cohen, J. Statistical Power Analysis for the Behavioral Sciences (Routledge, 2013).","DOI":"10.4324\/9780203771587"},{"key":"43177_CR47","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1086\/367939","volume":"76","author":"CR White","year":"2003","unstructured":"White, C. R. Allometric analysis beyond heterogeneous regression slopes: use of the Johnson-Neyman technique in comparative biology. Physiol. Biochem. Zool. PBZ. 76, 135\u2013140 (2003).","journal-title":"Physiol. Biochem. Zool. PBZ"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43177-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43177-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43177-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:41:15Z","timestamp":1781638875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43177-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43177"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43177-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was funded by Valbiotis. Valbiotis had a role in the study design, collection, analysis and interpretation of data, writing of the report and decision to submit the article for publication. Florian Le Joubioux is a Valbiotis employee. Vivien Chavanelle, Yolanda F. Otero, Doriane Ripoche are former Valbiotis employees. Thierry Maugard is a member of Valbiotis\u2019 scientific board. Sebastien Peltier is Valbiotis CEO. Pascal Sirvent is Valbiotis CSO. Ga\u00ebl Ennequin and Val\u00e9rie Hervieu declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12813"}}